Frontline immunotherapy and immune cold reprogramming across molecular subtypes of advanced endometrial cancer.
- DOI
- 10.1016/j.canlet.2026.218652
- Published
- 2026-06-04
- Container
- Cancer Lett
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.canlet.2026.218652,
title = {Frontline immunotherapy and immune cold reprogramming across molecular subtypes of advanced endometrial cancer.},
author = {Lin PH and Cheng SH and Raj EN and Wen ZH and Sheu JJ and Chang R and Chiang AJ and Li CJ.},
year = {2026},
journal = {Cancer Lett},
doi = {10.1016/j.canlet.2026.218652},
url = {https://doi.org/10.1016/j.canlet.2026.218652}
}RIS
TY - JOUR TI - Frontline immunotherapy and immune cold reprogramming across molecular subtypes of advanced endometrial cancer. AU - Lin PH AU - Cheng SH AU - Raj EN AU - Wen ZH AU - Sheu JJ AU - Chang R AU - Chiang AJ AU - Li CJ. PY - 2026 JO - Cancer Lett DO - 10.1016/j.canlet.2026.218652 UR - https://doi.org/10.1016/j.canlet.2026.218652 ER -
APA
PH, L., SH, C., EN, R., ZH, W., JJ, S., R, C., AJ, C., & CJ., L. (2026). Frontline immunotherapy and immune cold reprogramming across molecular subtypes of advanced endometrial cancer.. Cancer Lett. https://doi.org/10.1016/j.canlet.2026.218652
Source records
- europe-pmc · retrieved 2026-09-27T13:35:39.784Z